Septerna is offering a summer internship program with multiple positions available for ambitious undergraduate and graduate scientists. The program is designed for individuals passionate about contributing to and learning new skills in a biotech environment focused on developing new medications for patients. Internship opportunities are available in DMPK, protein biology, cellular biology, and medicinal chemistry, with a strong emphasis on drug discovery, GPCR research, and molecular pharmacology.

Richard M. van Rijn, Principal Scientist/Disease Biology lead and Adjunct Associate Professor in Medicinal Chemistry and Molecular Pharmacology, is involved in the program. Septerna is a values-driven organization advancing cutting-edge science and developing impactful new medicines for patients with significant unmet needs. The company culture emphasizes scientific rigor, collaboration, diversity, and results-driven innovation.

Interns will have the opportunity to work alongside experienced scientists, gain hands-on experience in drug discovery, and contribute to projects in key areas such as protein and cellular biology, medicinal chemistry, and DMPK. The program is ideal for students interested in biotechnology, molecular pharmacology, and related fields.

Applicants should be undergraduate or graduate students with a strong interest in science and biotechnology. While specific eligibility criteria such as GPA or language requirements are not mentioned, candidates are expected to be ambitious, intelligent, and eager to learn. The application process is conducted online via the Septerna careers page.

Funding details, including stipend or benefits for interns, are not specified in the announcement. However, Septerna highlights meaningful benefits and perks for employees, which may extend to interns. The deadline for applications is set for the Summer session, with a normalized date of 2026-10-01.

For more information and to apply, visit the Septerna careers page or follow the provided links.